Stock Earnings

Question 1

What are Dare Bioscience Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Dare Bioscience Inc has a total asset of $22, Net loss of $-4

Question 2

What are the key financial ratios for DARE?

Accepted Answer

Dare Bioscience Inc's Current ratio is 0.78, has a Net margin is 0, sales per share of $0.

Question 3

How is Dare Bioscience Inc's revenue broken down by segment or geography?

Accepted Answer

Dare Bioscience Inc largest revenue segment is Women's Health, at a revenue of 9,784 in the most earnings release.For geography, United States is the primary market for Dare Bioscience Inc, at a revenue of 9,784.

Question 4

Is Dare Bioscience Inc profitable?

Accepted Answer

no, according to the latest financial statements, Dare Bioscience Inc has a net loss of $-4

Question 5

Does Dare Bioscience Inc have any liabilities?

Accepted Answer

yes, Dare Bioscience Inc has liability of 28

Question 6

How many outstanding shares for Dare Bioscience Inc?

Accepted Answer

Dare Bioscience Inc has a total outstanding shares of 8.7

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	2	10	0	0
Revenue Growth (YoY)	-100%	-100%	-80%	--	--	--
Cost of Revenue	0	--	--	--	--	--
Gross Profit	0	--	--	--	--	--
Selling, General & Admin	6	9	12	11	8	6
Research & Development	6	14	21	30	30	20
Operating Expenses	13	23	33	41	39	27
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-13	-4	-30	-30	-38	-27
Income Tax Expense	--	0	--	--	--	--
Net Income	-13	-4	-30	-30	-38	-27
Net Income Growth	333%	-87%	0%	-21%	41%	80%
Shares Outstanding (Diluted)	12.75	8.49	7.27	84.57	61.15	30.09
Shares Change (YoY)	49%	17%	-91%	38%	103%	93%
EPS (Diluted)	-1.05	-0.47	-4.14	-0.37	-0.63	-0.91
EPS Growth	150%	-88%	1,019.99%	-41%	-31%	-6%
Free Cash Flow	-6	4	-39	-18	-28	-25
Free Cash Flow Per Share	-0.47	0.47	-5.36	-0.21	-0.45	-0.83
Gross Margin	0%	--	--	--	--	--
Operating Margin	0%	0%	-1,500%	-310%	0%	0%
Profit Margin	0%	0%	-1,500%	-300%	0%	0%
Free Cash Flow Margin	0%	0%	-1,950%	-180%	0%	0%
EBITDA	-12	-23	-30	-31	-39	-27
EBITDA Margin	0%	0%	-1,500%	-310%	0%	0%
D&A For EBITDA	1	0	0	0	0	0
EBIT	-13	-23	-30	-31	-39	-27
EBIT Margin	0%	0%	-1,500%	-310%	0%	0%
Effective Tax Rate	--	0%	--	--	--	--

Dare Bioscience Inc (DARE) Price

DARE Stock Price Chart

DARE Income

Follow-Up Questions